Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 94 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,434,000 | -11.1% | 168,795 | -6.7% | 0.21% | -11.2% |
| Q2 2022 | $2,738,000 | +3.9% | 180,933 | -18.4% | 0.23% | +12.1% |
| Q1 2022 | $2,635,000 | -57.8% | 221,774 | -42.5% | 0.21% | -48.1% |
| Q4 2021 | $6,248,000 | -38.0% | 385,440 | +9.2% | 0.40% | -36.2% |
| Q3 2021 | $10,070,000 | -6.9% | 352,839 | +10.3% | 0.62% | +13.8% |
| Q2 2021 | $10,817,000 | +97.1% | 320,032 | +76.3% | 0.55% | +50.8% |
| Q1 2021 | $5,488,000 | – | 181,492 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $932,939 | 3.08% |
| Sofinnova Investments, Inc. | 2,194,278 | $10,708,077 | 0.64% |
| Artal Group S.A. | 400,000 | $1,952 | 0.11% |
| Polar Capital Holdings Plc | 1,991,929 | $9,720,614 | 0.08% |
| ASHFORD CAPITAL MANAGEMENT INC | 98,870 | $482,486 | 0.08% |
| Soleus Capital Management, L.P. | 87,182 | $425,448 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 99,160 | $484 | 0.06% |
| Cormorant Asset Management, LP | 150,000 | $732 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 48,233 | $235,377 | 0.04% |
| XTX Topco Ltd | 38,574 | $188,241 | 0.04% |